. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Use of FISH Probes to Detect the t(4;14)(p16.3;q32) and t(14;16)(q32;q23) in Myeloma

Reference #:

2002-066

Inventors/Contributors

Rafael Fonseca, M.D., Philip R. Greipp, M.D.

Description

The invention provides methods and materials for determining a prognosis for myeloma and myeloma-disposed patients. The methods include the use of FISH techniques. The identification of the chromosomal abnormalities t(4;14)(p16;q32), t(14;16)(q32;q23), or 17p13 deletion (p53) in plasma cells from a patient indicates a poor prognosis.

Patent Status

Pending

Contact

Barbara A. Gamez Sims, Licensing Manager
gamezsims.barbara@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-8171
Fax: (507) 284-5410